Meetings & Events

Pediatric Residents Program

CARRA is a North American-based research organization of over 550 pediatric rheumatology investigators spanning more than 115 clinical practice sites. More than 95% of all board certified Pediatric Rheumatologists are members of CARRA. CARRA’s providers treat and study patients with all pediatric diseases such as JIA, lupus, dermatomyositis, localized scleroderma, systemic sclerosis, vasculitis, fibromyalgia, Kawasaki’s Disease, PFAPA, Sjögren’s Syndrome, CRMO, in addition to other auto-inflammatory diseases.

In the United States, 300,000 children are afflicted with arthritis and other rheumatic conditions, yet there are only (~360) pediatric rheumatologists across the country available to care for these children and half of children with rheumatic disease are seen by adult providers. To address the shortage of pediatric rheumatologists and to expose pediatric residents to the field of pediatric rheumatology, CARRA and the Arthritis Foundation are offering the Pediatric Residents Program.

The goals of the CARRA-Arthritis Foundation Pediatric Residents Program are to:

  • Provide pediatric residents with access to the broad pediatric rheumatologic community through participation in CARRA’s Annual Scientific Meeting. 
  • Encourage interested pediatric residents to consider pediatric rheumatology as a subspecialty, thus improve patient access to pediatric rheumatologists.
  • Introduce Pediatric Residents to the resources of the Arthritis Foundation.

To help achieve these goals, CARRA and the Arthritis Foundation are providing funds to support pediatric residents’ attendance at the Annual CARRA Scientific Meeting at the Hyatt Regency New Orleans in New Orleans, LA from April 26-29, 2020. Awardees will be teamed with a CARRA member from another state/institution who will help guide their experience at the meeting. 

APPLICATION REQUIREMENTS

To apply to the CARRA-Arthritis Foundation Pediatric Residents Program, including CARRA membership*, you will need to provide your contact information and a completed application. Your application must include the following items combined into one PDF document:

  1. Your CV 
  2. A personal statement: This should consist of less than one page describing yourself, your career goals, and reasons you would like to attend the CARRA meeting.
  3. Letter of support from your current program director. The letter needs to state that you will be allowed to attend the entire CARRA meeting (April 26-29, 2020).
  4. Letter of support from a current CARRA Member and/or a pediatric rheumatology mentor.

*Submitting your application to the CARRA-Arthritis Foundation Pediatric Residents Program includes applying for CARRA membership as a Trainee member. Membership is free for Trainees. Your Pediatric Residents Program application will serve as your membership application. You do not need to submit a separate membership application.

Applications are due by 11:59 PM PT on Wednesday, January 15, 2020. 

All applicants will be notified regarding the outcome of their applications by Wednesday, February 5, 2020.


TRAVEL SUPPORT

Travel support is made possible for this program through the generous support of the Arthritis Foundation (https://www.arthritis.org/). If you are selected to participate in the CARRA-Arthritis Foundation Pediatric Residents Program, you will be eligible to receive reimbursement for the following travel/meeting related costs as outlines below:

Eligible Expenses
Coach Airfare
(Shared) Hotel Room at the Conference Hotel, 4/26-4/29
Mileage and hotel parking (if driving to meeting location)
Taxi/shuttle to/from the New Orleans airport
Local Airport Parking Fees
Baggage Fees
Ineligible Expenses
Airfare upgrade, insurance or change fees
Rental cars
Meals
Mileage to/from your local airport
Passport or travel visa fees
Expenses submitted without the original receipt

We will pair you with another resident to share a hotel room.  You may stay in a private room; however, you will be responsible for the additional costs. CARRA will not charge a meeting registration fee and will provide group meals to conference attendees during the conference.

REQUIREMENTS/RESTRICTIONS

  • Awardees are required to attend the full CARRA meeting and complete a meeting evaluation.
  • Travel reimbursement will be provided following completion of the meeting.
  • Scanned copies of all receipts are required for reimbursement.
  • All reimbursement will be provided after the meeting.

PRSYM

The American College of Rheumatology’s Pediatric Rheumatology Symposium (PRSYM) will take place April 29-May 2, also at the Hyatt Regency New Orleans. We encourage all residents to attend PRSYM, as well. Additional travel support is available for residents who are able to stay for both CARRA and PRSYM as outlined below:

1. Residents who have abstracts accepted by PRSYM are eligible to receive up to $1000 in travel expenses (including airfare, hotel, and meals) plus complimentary meeting registration to attend PRSYM. This award is through the Rheumatology Research Foundation Abstract Award.  All CARRA-Arthritis Foundation Residents Program applicants who wish to stay for PRSYM are encouraged to submit abstracts for this award, however please know that this option is open to any/all residents (regardless of participation in our program).  For more information on abstract submissions, see https://www.rheumatology.org/Learning-Center/Educational-Activities/View/ID/1031

You must submit your abstract(s) to PRSYM by 5pm ET on January 15. Submissions open November 20.

2. Participants in the CARRA Pediatric Residents program who attend the full CARRA conference and do not have an abstract accepted by PRSYM will be eligible to receive additional lodging support (1/2 of double occupancy charges). No additional expenses (meals, meeting registration) will be covered.

3. If you receive a travel award from ACR, the support from this program will be supplemental, e.g., you will be expected to use the ACR travel award for your airfare and lodging during the PRSYM meeting.


CARRA’s Mission
CARRA’s mission is to conduct collaborative research to prevent, treat and cure pediatric rheumatic diseases and its largest research project is called the CARRA Registry. The CARRA Registry is a long-term observational study being conducted at over 70 research sites in the US and Canada. The CARRA Registry is studying the long-term safety of medications used to treat pediatric rheumatic diseases, and will follow at least 10,000 patients for 10 years.  CARRA also participates in clinical trials and has a growing internal grant program, funded in large part by the Arthritis Foundation.

CARRA’s Vision
A world free of limitations from pediatric rheumatic diseases.


QUESTIONS

For any questions about the CARRA-Arthritis Foundation Pediatric Residents Program or application, please contact CARRA’s Director of Administration, Brian Mondragón Jones ([email protected]).